Episode 12: Dale Bredesen discusses the metabolic factors underlying Alzheimer’s Disease

Summary: Dr. Dale Bredesen says Alzheimer’s Disease is the third leading cause of death in the United States. Dr. Bredesen has developed a novel therapeutic approach that addresses the underlying metabolic changes leading to development of the disease. <br> <br> Dr. Bredesen’s approach, called MEND (metabolic enhancement for neurodegeneration) helped a 65-year-old woman recover her functional memory, after her first physician had written her off as bound to the same demise of her mother, who suffered and died from Alzheimer’s Disease. <br> <br> Bredesen shares these and other insights in this episode of STEM-Talk, where he and host Dawn Kernagis engage in a rich and thought-provoking conversation about the future of treating neurodegenerative and other diseases. <br> <br> Bredesen has been on the faculty at UCSF, UCSD. Currently, he divides his time between UCLA and the Buck Institute for Research on Aging, of which he is founder and CEO: http://buckinstitute.org/bredesenLab